Evidence map›Paper›PMID 25518016›Full record

ArticleClinics (Sao Paulo, Brazil)2014

The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors.

Bernardo Gomes de Lacerda Almeida, Carlos E Bacchi, Jesus P Carvalho, Cristiane R Ferreira, Filomena M Carvalho

Open access · goldAbstract read
In one paragraph

Article in Clinics (Sao Paulo, Brazil), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Probing mucin interaction behavior of magnetic nanoparticles.Journal of colloid and interface science · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bernardo Gomes de Lacerda AlmeidaDepartment of Pathology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Carlos E BacchiBotucatu - Consultoria em Patologia, Laboratório Bacchi, Botucatu, SP, Brazil.
Jesus P CarvalhoObstetrics and Gynecology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Cristiane R FerreiraDepartment of Pathology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Filomena M CarvalhoDepartment of Pathology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOvarian mucinous metastases commonly present as the first sign of the disease and are capable of simulating primary tumors. Our aim was to investigate the role of intratumoral lymphatic vascular density together with other surgical-pathological features in distinguishing primary from secondary mucinous ovarian tumors.

methodsA total of 124 cases of mucinous tumors in the ovary (63 primary and 61 metastatic) were compared according to their clinicopathological features and immunohistochemical profiles. The intratumoral lymphatic vascular density was quantified by counting the number of vessels stained by the D2-40 antibody.

resultsMetastases occurred in older patients and were associated with a higher proportion of tumors smaller than 10.0 cm; bilaterality; extensive necrosis; extraovarian extension; increased expression of cytokeratin 20, CDX2, CA19.9 and MUC2; and decreased expression of cytokeratin 7, CA125 and MUC5AC. The lymphatic vascular density was increased among primary tumors. However, after multivariate analysis, the best predictors of a secondary tumor were a size of 10.0 cm or less, bilaterality and cytokeratin 7 negativity. Lack of MUC2 expression was an important factor excluding metastasis.

conclusionsThe higher intratumoral lymphatic vascular density in primary tumors when compared with secondary lesions suggests differences in the microenvironment. However, considering the differential diagnosis, the best discriminator of a secondary tumor is the combination of tumor size, laterality and the pattern of expression of cytokeratin 7 and MUC2.

Indexed as

Adenocarcinoma, MucinousAdolescentAdultAgedAged, 80 and overBiomarkers, TumorCA-125 AntigenDiagnosis, DifferentialFemaleHumansImmunohistochemistryKeratinsLymphatic MetastasisLymphatic VesselsMembrane GlycoproteinsMembrane ProteinsBiomarkers, TumorCA-125 AntigenKeratinsMembrane GlycoproteinsMembrane ProteinsMUC16 protein, humanMucinsPDPN protein, humanPodoplanin

Identifiers

PMID25518016
PMCPMC4221329
OpenAlexW1971374204

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.